Molecular Formula | C15H24O2 |
Molar Mass | 236.35 |
Density | 0.971±0.06 g/cm3(Predicted) |
Melting Point | 72.5-73°C |
Boling Point | 357.8±37.0 °C(Predicted) |
Appearance | powder to crystal |
Color | White to Light yellow to Dark green |
pKa | 11.22±0.30(Predicted) |
Storage Condition | Inert atmosphere,2-8°C |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 4.195 ml | 20.976 ml | 41.952 ml |
5 mM | 0.839 ml | 4.195 ml | 8.39 ml |
10 mM | 0.42 ml | 2.098 ml | 4.195 ml |
5 mM | 0.084 ml | 0.42 ml | 0.839 ml |
biological activity | HTHQ (1-O-hexyl-2,3, 5-trimethhylhydrotron) is a potent lipophilic phenolic antioxidant. HTHQ has a strong antioxidant activity by reacting directly with reactive oxygen species (ROS) and scavenging ROS to form more stable free radicals. |
Target | ROS |
Cell Line: | PC12 cells PC12 cells |
Concentration: | 0 μM, 1 μM, 10 μM, and 100 μM 10 μM |
Incubation Time: | 24 hours 0.6-24 hours |
Result: | Reduced cell viability at 24 hours caused by both 100 and 200 µM L-DOPA was significantly attenuated. Inhibited L-DOPA-induced phosphorylation of sustained extracellular signal-regulated kinases (ERK1/2), p38 mitogen-activated protein kinase (MAPK), and c-Jun N-terminal kinase (JNK1/2). And also normalized L-DOPA-reduced Bcl-2-associated death protein (Bad) phosphorylation and Bcl-2-associated X protein (Bax) expression. Improved against DMN-induced liver fibrosis in male SD rats. |
Animal Model: | 48 specific pathogen-free male Sprague Dawley (SD) rats (6-week-old ) with dimethylnitrosamine (DMN) |
Dosage: | 50 mg/kg, 100 mg/kg, 200 mg/kg |
Administration: | Oral administration; for 4 weeks |